Villejuif, France

Romain Daillere

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Romain Daillere

Introduction

Romain Daillere is a prominent inventor based in Villejuif, France, known for his groundbreaking work in the field of oncology. With two patents to his name, Daillere is paving the way for innovative approaches to cancer treatment by exploring the role of microbiota in patient responses to chemotherapy.

Latest Patents

Romain Daillere's most recent patents include "Microbiota composition, as a marker of responsiveness to chemotherapy," and "Use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of cancer treatment." These inventions focus on methods that determine whether a patient is likely to benefit from cancer treatments based on their gut microbiome. Specifically, the patents highlight the association between gut dysbiosis and certain bacterial species' overrepresentation. Furthermore, the inventions introduce probiotic strains aimed at enhancing the efficacy of chemotherapy for patients who require such interventions.

Career Highlights

Throughout his career, Romain Daillere has been associated with esteemed institutions such as the Institut Gustave Roussy and the Institut National de la Santé et de la Recherche Médicale. His dedication to cancer research and treatment innovation has positioned him as a key player in the scientific community, particularly in the realm of microbiota and its impact on health outcomes.

Collaborations

Daillere has collaborated with notable figures in his field, including Laurence Zitvogel and Ivo Gomperts Boneca. These partnerships have fostered exciting research opportunities and have contributed to the advancement of understanding in cancer treatments and microbiome interactions.

Conclusion

Romain Daillere's work exemplifies the importance of innovation in medical research, particularly in oncology. His patents underscore the potential of utilizing microbiota as a pivotal element in determining treatment efficacy, highlighting a promising frontier in cancer therapy. As research continues to evolve, Daillere's contributions may significantly impact the future of personalized cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…